Glycogen synthase 3 (GSK-3) regulation of PD-1 expression and and its therapeutic implications.
Sign Up to like & getrecommendations! Published in 2019 at "Seminars in immunology"
DOI: 10.1016/j.smim.2019.101295
Abstract: The past few years have witnessed exciting progress in the application of immune check-point blockade (ICB) for the treatment of various human cancers. ICB was first used against cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to demonstrate… read more here.
Keywords: gsk regulation; synthase gsk; glycogen synthase; regulation ... See more keywords